COMPASS-LTOLE
A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
- Stadium
- klaar
- Middel
- rivaroxaban
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 1 januari 2018
- Last Patient In
- -
- Last Patient Last Visit
- -
National Lead
dr. A.M.W. Alings
Cardioloog
Studiedirecteur
